Compared with its peers, Mylan 's less diversified operations increase ..... volatility in generic drug markets. Mylan faces considerable competition from low ..... Aggressive entry pricing could weaken Mylan 's dominant market position. Mylan
line growth more quickly than top-line growth.Abbott's sale of it established pharma business in developed markets to Mylan and its acquisition of CFR and Veropharm have put Abbott's branded generics business in a strong position to benefit from
By Valuentum : Abbott (NYSE: ABT ) has a track record that is unrivaled. The firm is more than 125 years old and remains aligned with favorable long-term healthcare trends in both developed and developing markets. We believe Abbott's nutritionals segment is one of the most attractive businesses in
the District of New Jersey grants Mylan 's (NASDAQ: MYL ) motion for a permanent injunction ..... product. The Court also awards Mylan prejudgment interest and permits ..... trial motions. The Court awarded Mylan $106.7M in damages after a favorable
acquisitions of CFR and Veropharm, along with the divestment of Abbott's established pharmaceuticals in the developed markets to Mylan . Importantly, Abbott made progress on profitability as it held manufacturing and operating costs down. We continue to
* Portfolio has sales of 2.1 bln eur, enterprise value 6.3 bln eur
PARIS, July 16 (Reuters) - Sanofi has held talks with Abbott Laboratories, Mylan and private equity firms over the possible sale of a 6.3 billion euro ($8.5 billion) portfolio of mature drugs,...
By The Value Investor : Mylan (NASDAQ: MYL ) has announced a much anticipated ..... surprise but does mark a big step for Mylan to achieve its long-term earnings ..... at current levels. Deal Highlights Mylan announced that it has reached an agreement
(Reuters) - Generic drugmaker Mylan Inc said on Monday it would buy Abbott Laboratories' branded specialty and generics business in developed markets outside the United States in a $5.3 billion deal that will bolster its product line and also cut its tax bill.
(Adds analyst comments, details of deal, company background, stock prices)